LIDOCAINE PATCH

LIDOCAINE PATCH was reported 7762 times

LIDOCAINE PATCH is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPLICATION SITE COLDNESS 9 0.1059
1 PRODUCT ADHESION ISSUE 2863 0.0800
2 RENAL FUNCTION TEST 2 0.0645
3 PRECANCEROUS LESION EXCISION 1 0.0385
4 EXFOLIATION GLAUCOMA 1 0.0357
5 APPLICATION SITE DISCOMFORT 63 0.0350
6 APPLICATION SITE PERSPIRATION 6 0.0347
7 APPLICATION SITE LACERATION 14 0.0338
8 ALLERGY TO SURGICAL SUTURES 1 0.0233
9 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1263 0.0230
10 JOINT DEPOSIT 1 0.0213
11 PRODUCT QUALITY ISSUE 2679 0.0197
12 INFUSION SITE EXFOLIATION 1 0.0192
13 SKIN LESION REMOVAL 1 0.0185
14 APPLICATION SITE ALOPECIA 1 0.0182
15 PERONEAL MUSCULAR ATROPHY 1 0.0167
16 PRODUCT DIFFICULT TO REMOVE 1 0.0167
17 WEIGHT CONTROL 1 0.0159
18 APPLICATION SITE INJURY 3 0.0158
19 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 97 0.0157
20 APPLICATION SITE MASS 4 0.0146
21 RADICULOTOMY 1 0.0145
22 WEIGHT LOSS DIET 1 0.0135
23 CRYOTHERAPY 1 0.0135
24 CHRONIC LYMPHOCYTIC LEUKAEMIA REFRACTORY 1 0.0106
25 APPLICATION SITE HYPERAESTHESIA 1 0.0101
26 CARDIAC INDEX DECREASED 1 0.0097
27 SUTURE REMOVAL 1 0.0093
28 PRODUCT DESIGN ISSUE 6 0.0084
29 APPLICATION SITE ACNE 4 0.0082
30 BURKHOLDERIA TEST POSITIVE 1 0.0081
31 HEREDITARY MOTOR AND SENSORY NEUROPATHY 1 0.0076
32 NEUROPROSTHESIS IMPLANTATION 1 0.0072
33 CIRCUMCISION 1 0.0071
34 IMPLANT SITE VESICLES 1 0.0068
35 LIVER OPERATION 2 0.0065
36 MEDICAL DEVICE SITE REACTION 1 0.0063
37 THORACIC OPERATION 1 0.0061
38 APPLICATION SITE IRRITATION 75 0.0060
39 REACTION TO AZO-DYES 1 0.0058
40 PULMONARY ARTERIAL WEDGE PRESSURE INCREASED 1 0.0057
41 EXAGGERATED STARTLE RESPONSE 1 0.0055
42 LIMB IMMOBILISATION 1 0.0054
43 APPLICATION SITE RASH 74 0.0054
44 EXPOSURE TO EXTREME TEMPERATURE 1 0.0052
45 VOLVULUS OF SMALL BOWEL 1 0.0051
46 MEDICAL DIET 1 0.0051
47 APPLICATION SITE HYPERSENSITIVITY 6 0.0049
48 RETINAL DEPOSITS 1 0.0049
49 HERNIA HIATUS REPAIR 1 0.0049
50 PERITONEAL ABSCESS 1 0.0047
51 APPLICATION SITE PAPULES 5 0.0047
52 APPLICATION SITE WARMTH 6 0.0047
53 CLOSTRIDIUM BACTERAEMIA 1 0.0047
54 HEARING AID USER 2 0.0047
55 NEUROMUSCULAR BLOCKADE 1 0.0045
56 APPLICATION SITE HYPOAESTHESIA 1 0.0043
57 PULMONARY RESECTION 1 0.0040
58 APPLICATION SITE EROSION 5 0.0039
59 SUPERFICIAL VEIN PROMINENCE 1 0.0039
60 PRODUCT AVAILABILITY ISSUE 88 0.0039
61 APPLICATION SITE PARAESTHESIA 5 0.0038
62 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 10 0.0038
63 INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION 2 0.0037
64 TRAUMATIC HAEMOTHORAX 1 0.0036
65 BURNS FIRST DEGREE 1 0.0035
66 JOINT FLUID DRAINAGE 1 0.0035
67 EXPIRED PRODUCT ADMINISTERED 114 0.0034
68 FROSTBITE 1 0.0033
69 RESTRICTIVE CARDIOMYOPATHY 1 0.0033
70 FEEDING TUBE COMPLICATION 1 0.0032
71 APPLICATION SITE URTICARIA 7 0.0031
72 APPLICATION SITE PAIN 68 0.0031
73 APPLICATION SITE BRUISE 3 0.0031
74 MULTIPLE SCLEROSIS PSEUDO RELAPSE 1 0.0029
75 SPINAL NERVE STIMULATOR IMPLANTATION 1 0.0029
76 APPLICATION SITE VESICLES 19 0.0029
77 LIVER FUNCTION TEST DECREASED 1 0.0028
78 PRODUCT COMPOUNDING QUALITY ISSUE 1 0.0027
79 INABILITY TO AFFORD MEDICATION 27 0.0027
80 XANTHOPSIA 1 0.0027
81 FIBROCYSTIC BREAST DISEASE 2 0.0027
82 SPINAL FUSION SURGERY 11 0.0027
83 APPLICATION SITE PRURITUS 60 0.0026
84 SKIN DISCHARGE 1 0.0026
85 NECK SURGERY 6 0.0026
86 APPLICATION SITE REACTION 18 0.0026
87 MANUFACTURING MATERIALS ISSUE 1 0.0025
88 APPLICATION SITE EXFOLIATION 10 0.0024
89 EXPOSURE VIA EYE CONTACT 1 0.0024
90 BONE SCAN ABNORMAL 1 0.0024
91 APPLICATION SITE ERYTHEMA 61 0.0023
92 RETINAL PIGMENT EPITHELIOPATHY 1 0.0023
93 BODY HEIGHT DECREASED 24 0.0022
94 LOCALISED INTRAABDOMINAL FLUID COLLECTION 1 0.0022
95 MUSCLE MASS 1 0.0022
96 NEUROMA 1 0.0022
97 THERAPEUTIC PRODUCT EFFECT PROLONGED 1 0.0022
98 APPLICATION SITE HAEMORRHAGE 6 0.0022
99 ALLERGY TO PLANTS 1 0.0022
100 BILIARY SEPSIS 1 0.0022
101 APPLICATION SITE DERMATITIS 2 0.0021
102 OPIATES POSITIVE 1 0.0021
103 DERMATITIS INFECTED 1 0.0020
104 PHYSIOTHERAPY 1 0.0019
105 CYST REMOVAL 1 0.0019
106 PROCEDURAL SITE REACTION 1 0.0019
107 FRACTURE OF PENIS 1 0.0019
108 INCORRECT PRODUCT ADMINISTRATION DURATION 41 0.0019
109 DRUG EFFECT PROLONGED 1 0.0018
110 SPINAL OPERATION 22 0.0018
111 INSURANCE ISSUE 27 0.0018
112 NAIL INJURY 1 0.0018
113 SURGICAL FAILURE 2 0.0017
114 NERVE BLOCK 1 0.0017
115 SUTURE INSERTION 1 0.0017
116 NO ADVERSE EVENT 302 0.0017
117 ALLERGY TO METALS 1 0.0016
118 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 333 0.0016
119 SHOULDER OPERATION 7 0.0016
120 BLADDER PROLAPSE 2 0.0016
121 OFF LABEL USE 1412 0.0016
122 APPLICATION SITE SWELLING 8 0.0016
123 MULTIPLE USE OF SINGLE-USE PRODUCT 9 0.0016
124 APPLICATION SITE SCAR 2 0.0016
125 BLOOD PRESSURE MEASUREMENT 1 0.0016
126 REFLEXES ABNORMAL 1 0.0015
127 RENAL SURGERY 1 0.0015
128 APPLICATION SITE INFLAMMATION 2 0.0014
129 GRAVITATIONAL OEDEMA 1 0.0014
130 SUTURE RUPTURE 1 0.0014
131 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0014
132 MYOFASCIAL PAIN SYNDROME 1 0.0014
133 CERVICAL RADICULOPATHY 1 0.0014
134 EOSINOPHILIC MYOCARDITIS 1 0.0014
135 DIET REFUSAL 1 0.0014
136 BENIGN NEOPLASM OF THYROID GLAND 1 0.0014
137 COMPLEX REGIONAL PAIN SYNDROME 2 0.0014
138 VITAMIN B COMPLEX DEFICIENCY 1 0.0013
139 OESOPHAGEAL DISCOMFORT 1 0.0013
140 PRODUCT CONFUSION 1 0.0013
141 TUMOUR EXCISION 1 0.0012
142 ABDOMINAL SYMPTOM 1 0.0012
143 PENILE HAEMORRHAGE 1 0.0012
144 TONGUE ERYTHEMA 1 0.0012
145 VERTEBRAL FORAMINAL STENOSIS 1 0.0012
146 INCORRECT DRUG ADMINISTRATION DURATION 33 0.0012
147 TONGUE MOVEMENT DISTURBANCE 1 0.0012
148 ALLERGIC SINUSITIS 1 0.0012
149 THYROIDECTOMY 2 0.0012
150 ARTERIAL STENOSIS 1 0.0011
151 CARDIAC ABLATION 2 0.0011
152 SHOULDER ARTHROPLASTY 3 0.0011
153 SKIN DISCOMFORT 3 0.0011
154 HIP SURGERY 6 0.0011
155 FOREIGN BODY IN EYE 1 0.0010
156 APPLICATION SITE BURN 5 0.0010
157 DRUG SCREEN POSITIVE 8 0.0010
158 SPUTUM RETENTION 1 0.0010
159 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 1 0.0010
160 PRODUCT MEASURED POTENCY ISSUE 1 0.0010
161 FALSE POSITIVE INVESTIGATION RESULT 1 0.0010
162 EMERGENCY CARE 3 0.0010
163 APPLICATION SITE DISCOLOURATION 4 0.0010
164 PRODUCT COLOUR ISSUE 5 0.0010
165 BLADDER DYSFUNCTION 1 0.0010
166 LIGHT CHAIN ANALYSIS INCREASED 1 0.0010
167 INADEQUATE ANALGESIA 8 0.0009
168 ALLERGY TO ANIMAL 1 0.0009
169 REACTION TO DRUG EXCIPIENTS 2 0.0009
170 BLOOD TESTOSTERONE ABNORMAL 1 0.0009
171 FACIAL SPASM 1 0.0009
172 DRUG EFFECT VARIABLE 1 0.0009
173 THERAPEUTIC PRODUCT EFFECT DELAYED 4 0.0009
174 BRAIN OPERATION 2 0.0009
175 CHEMICAL BURN 1 0.0009
176 PROGRESSIVE MULTIPLE SCLEROSIS 1 0.0009
177 METHAEMOGLOBINAEMIA 2 0.0009
178 BLADDER OPERATION 1 0.0009
179 INCISION SITE PAIN 1 0.0009
180 BILE DUCT STENOSIS 1 0.0008
181 CHRONIC RESPIRATORY FAILURE 1 0.0008
182 RECTAL PROLAPSE 1 0.0008
183 SECONDARY IMMUNODEFICIENCY 1 0.0008
184 PENILE SWELLING 1 0.0008
185 FOOT OPERATION 4 0.0008
186 INTERVERTEBRAL DISC OPERATION 1 0.0008
187 PRODUCT USED FOR UNKNOWN INDICATION 1 0.0008
188 GASTRIC ULCER PERFORATION 1 0.0008
189 DERMATITIS CONTACT 9 0.0008
190 CARDIAC VENTRICULAR THROMBOSIS 1 0.0008
191 PROTEIN TOTAL ABNORMAL 1 0.0008
192 PRODUCT PACKAGING DIFFICULT TO OPEN 2 0.0008
193 LUNG OPACITY 2 0.0008
194 PRODUCT SIZE ISSUE 4 0.0007
195 PRODUCT PACKAGING ISSUE 7 0.0007
196 CLUSTER HEADACHE 1 0.0007
197 INFUSION SITE RASH 1 0.0007
198 THERAPEUTIC PROCEDURE 1 0.0007
199 PRECANCEROUS CELLS PRESENT 1 0.0007
200 POST HERPETIC NEURALGIA 1 0.0007
201 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
202 JUDGEMENT IMPAIRED 1 0.0007
203 WRONG PATIENT RECEIVED PRODUCT 2 0.0007
204 NECK INJURY 2 0.0007
205 LIGAMENT RUPTURE 3 0.0007
206 ANKLE OPERATION 1 0.0007
207 THORACIC VERTEBRAL FRACTURE 2 0.0007
208 TOBACCO USER 1 0.0007
209 WHEELCHAIR USER 3 0.0007
210 HYPERCAPNIA 2 0.0007
211 MOUTH INJURY 1 0.0007
212 PALLIATIVE CARE 1 0.0007
213 HIP ARTHROPLASTY 10 0.0007
214 ORAL MUCOSAL ERUPTION 1 0.0007
215 DAYDREAMING 1 0.0006
216 MEDICAL DEVICE IMPLANTATION 1 0.0006
217 MEGACOLON 1 0.0006
218 DRUG EFFECT INCREASED 2 0.0006
219 DRUG EFFECT DECREASED 34 0.0006
220 COSTOCHONDRITIS 1 0.0006
221 WALKING AID USER 4 0.0006
222 PROTEIN URINE PRESENT 3 0.0006
223 SPINAL DEFORMITY 1 0.0006
224 SEIZURE LIKE PHENOMENA 1 0.0006
225 CERVICAL SPINAL STENOSIS 1 0.0006
226 TREATMENT DELAYED 1 0.0006
227 MASTECTOMY 1 0.0006
228 ROTATOR CUFF REPAIR 1 0.0006
229 BURNS SECOND DEGREE 1 0.0006
230 SKIN HYPOPIGMENTATION 1 0.0006
231 INDURATION 1 0.0006
232 DRUG MONITORING PROCEDURE NOT PERFORMED 1 0.0006
233 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
234 PNEUMOPERITONEUM 1 0.0005
235 ACCIDENTAL DEATH 1 0.0005
236 BLOOD CHOLESTEROL DECREASED 1 0.0005
237 NARCOLEPSY 1 0.0005
238 OESOPHAGEAL DISORDER 2 0.0005
239 COLOSTOMY 1 0.0005
240 KNEE OPERATION 5 0.0005
241 DRUG DELIVERY SYSTEM ISSUE 1 0.0005
242 CATARACT OPERATION 3 0.0005
243 PRODUCT SUBSTITUTION ISSUE 29 0.0005
244 SCIATICA 8 0.0005
245 PRODUCT PHYSICAL ISSUE 10 0.0005
246 ENURESIS 2 0.0005
247 GALLBLADDER OPERATION 2 0.0005
248 PERIPHERAL ISCHAEMIA 2 0.0005
249 TRIGGER FINGER 2 0.0005
250 MENISCUS INJURY 3 0.0005
251 SKIN INDURATION 1 0.0005
252 SLEEP DEFICIT 1 0.0005
253 EAR SWELLING 1 0.0005
254 TORTICOLLIS 1 0.0005
255 APPLICATION SITE SCAB 1 0.0005
256 INFUSION SITE BRUISING 1 0.0005
257 BONE CANCER 2 0.0005
258 PRODUCT USE IN UNAPPROVED INDICATION 113 0.0005
259 BIPOLAR I DISORDER 1 0.0005
260 ACCIDENT AT WORK 1 0.0005
261 SPINAL COLUMN INJURY 1 0.0004
262 CORNEAL OEDEMA 1 0.0004
263 DIVERTICULUM INTESTINAL HAEMORRHAGIC 1 0.0004
264 INFUSION SITE INFECTION 1 0.0004
265 UMBILICAL HERNIA 2 0.0004
266 VARICELLA 1 0.0004
267 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
268 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 29 0.0004
269 THERAPY CHANGE 4 0.0004
270 PANCREATIC DISORDER 2 0.0004
271 DEVICE INFUSION ISSUE 1 0.0004
272 RETINAL ARTERY OCCLUSION 1 0.0004
273 DRUG TOLERANCE 2 0.0004
274 TOXIC ENCEPHALOPATHY 2 0.0004
275 APPENDICITIS PERFORATED 1 0.0004
276 LACTOSE INTOLERANCE 1 0.0004
277 CONCUSSION 3 0.0004
278 FAILURE TO THRIVE 2 0.0004
279 DRUG INEFFECTIVE 505 0.0004
280 PRODUCT USE COMPLAINT 6 0.0004
281 KNEE ARTHROPLASTY 8 0.0004
282 SCRATCH 4 0.0004
283 ANIMAL BITE 1 0.0004
284 MIDDLE INSOMNIA 7 0.0004
285 HYPOACUSIS 16 0.0004
286 FRUSTRATION TOLERANCE DECREASED 3 0.0004
287 FIBROMYALGIA 9 0.0004
288 NERVE INJURY 4 0.0004
289 CHOLECYSTITIS ACUTE 2 0.0004
290 VITAMIN B12 DECREASED 1 0.0003
291 LUNG CANCER METASTATIC 1 0.0003
292 MUSCLE STRAIN 3 0.0003
293 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
294 ESCHERICHIA SEPSIS 1 0.0003
295 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
296 RESPIRATORY RATE INCREASED 3 0.0003
297 PAIN 207 0.0003
298 URINE ANALYSIS ABNORMAL 1 0.0003
299 PENILE PAIN 1 0.0003
300 MEDICAL DEVICE DISCOMFORT 1 0.0003
301 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
302 SCOLIOSIS 2 0.0003
303 RESPIRATORY RATE DECREASED 1 0.0003
304 INFUSION SITE PRURITUS 1 0.0003
305 ROTATOR CUFF SYNDROME 4 0.0003
306 LOOSE TOOTH 1 0.0003
307 SKIN EROSION 1 0.0003
308 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 22 0.0003
309 INTENTIONAL PRODUCT MISUSE 27 0.0003
310 INCORRECT DISPOSAL OF PRODUCT 1 0.0003
311 FACET JOINT SYNDROME 1 0.0003
312 BRADYPHRENIA 2 0.0003
313 LISTLESS 1 0.0003
314 EXPIRED DEVICE USED 1 0.0003
315 NEPHRITIS 1 0.0003
316 ANXIETY DISORDER 1 0.0003
317 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
318 METASTASES TO SPINE 1 0.0003
319 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 1 0.0003
320 APPLICATION SITE DRYNESS 1 0.0003
321 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 2 0.0003
322 CERVICAL VERTEBRAL FRACTURE 1 0.0003
323 TACHYPHRENIA 1 0.0003
324 HYPOPNOEA 1 0.0003
325 HANGOVER 1 0.0003
326 THROMBOTIC THROMBOCYTOPENIC PURPURA 1 0.0003
327 INCONTINENCE 3 0.0003
328 JOINT DISLOCATION 3 0.0003
329 MACULOPATHY 1 0.0003
330 THERMAL BURN 2 0.0003
331 FACIAL BONES FRACTURE 1 0.0003
332 BACK INJURY 3 0.0003
333 LIVER TRANSPLANT 1 0.0003
334 SPONDYLITIS 1 0.0003
335 DEVICE KINK 1 0.0003
336 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 5 0.0003
337 PARADOXICAL DRUG REACTION 1 0.0003
338 WOUND HAEMORRHAGE 1 0.0003
339 GAIT INABILITY 9 0.0003
340 RETINOPATHY 1 0.0003
341 SNORING 1 0.0003
342 SKIN IRRITATION 12 0.0003
343 DEVICE ADHESION ISSUE 4 0.0003
344 OESOPHAGEAL ULCER 1 0.0003
345 ACUTE RESPIRATORY FAILURE 5 0.0003
346 ANKLE FRACTURE 4 0.0003
347 SPINAL CORD COMPRESSION 1 0.0003
348 ORAL INFECTION 1 0.0003
349 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
350 POLYDIPSIA 1 0.0003
351 HYPERPHAGIA 1 0.0003
352 SPINAL FRACTURE 5 0.0002
353 HYPERHIDROSIS 32 0.0002
354 DRUG EFFECT INCOMPLETE 9 0.0002
355 DECUBITUS ULCER 2 0.0002
356 RECURRENT CANCER 1 0.0002
357 RIB FRACTURE 5 0.0002
358 DERMATITIS ALLERGIC 3 0.0002
359 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
360 POOR PERIPHERAL CIRCULATION 1 0.0002
361 INTERVERTEBRAL DISC DISORDER 1 0.0002
362 PRODUCT DISPENSING ISSUE 1 0.0002
363 CARDIAC OPERATION 2 0.0002
364 TENSION HEADACHE 1 0.0002
365 TEARFULNESS 1 0.0002
366 DYSPHEMIA 1 0.0002
367 SPINAL OSTEOARTHRITIS 2 0.0002
368 VULVOVAGINAL DISCOMFORT 1 0.0002
369 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 2 0.0002
370 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
371 MENINGITIS ASEPTIC 1 0.0002
372 SURGERY 13 0.0002
373 DRUG EFFECT DELAYED 1 0.0002
374 URINE ABNORMALITY 1 0.0002
375 EXOSTOSIS 2 0.0002
376 PERIPHERAL COLDNESS 3 0.0002
377 EYE OPERATION 1 0.0002
378 PRODUCT DISTRIBUTION ISSUE 2 0.0002
379 RENAL FUNCTION TEST ABNORMAL 1 0.0002
380 MASS 3 0.0002
381 CARPAL TUNNEL SYNDROME 3 0.0002
382 FLANK PAIN 2 0.0002
383 DISCOMFORT 13 0.0002
384 SKIN ABRASION 1 0.0002
385 SPINAL DISORDER 2 0.0002
386 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
387 MEDICATION RESIDUE PRESENT 1 0.0002
388 LIMB OPERATION 1 0.0002
389 HUMERUS FRACTURE 1 0.0002
390 NEURALGIA 5 0.0002
391 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 37 0.0002
392 INCORRECT DOSAGE ADMINISTERED 1 0.0002
393 COELIAC DISEASE 2 0.0002
394 VENOOCCLUSIVE LIVER DISEASE 1 0.0002
395 HYPERVOLAEMIA 1 0.0002
396 DISABILITY 4 0.0002
397 LIGAMENT SPRAIN 2 0.0002
398 UPPER LIMB FRACTURE 4 0.0002
399 BRAIN INJURY 2 0.0002
400 TOE AMPUTATION 1 0.0002
401 DRY THROAT 2 0.0002
402 MOBILITY DECREASED 14 0.0002
403 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
404 CEREBRAL ISCHAEMIA 1 0.0002
405 PRODUCT STORAGE ERROR 17 0.0002
406 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
407 VENTRICULAR EXTRASYSTOLES 2 0.0002
408 MUSCULOSKELETAL PAIN 10 0.0002
409 PRODUCT DOSE OMISSION ISSUE 56 0.0002
410 FOOD CRAVING 1 0.0002
411 ANAL ABSCESS 1 0.0002
412 PRODUCT RESIDUE PRESENT 1 0.0002
413 DECREASED ACTIVITY 2 0.0002
414 STRESS FRACTURE 1 0.0002
415 BACK DISORDER 3 0.0002
416 ASPIRATION 2 0.0002
417 FAECALOMA 1 0.0002
418 DEAFNESS UNILATERAL 1 0.0002
419 TOOTH FRACTURE 2 0.0002
420 DENTAL CARIES 2 0.0002
421 MENTAL STATUS CHANGES 5 0.0002
422 SKIN DISORDER 6 0.0002
423 HEART RATE ABNORMAL 1 0.0002
424 PERICARDITIS 3 0.0002
425 INTENTIONAL DOSE OMISSION 5 0.0002
426 MUSCULOSKELETAL DISCOMFORT 3 0.0002
427 CORONARY ARTERY BYPASS 1 0.0002
428 SKIN ATROPHY 1 0.0002
429 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
430 PRODUCT LABEL CONFUSION 1 0.0002
431 DYSSTASIA 5 0.0002
432 HYPOVOLAEMIA 1 0.0002
433 URINE ODOUR ABNORMAL 1 0.0002
434 DECREASED INTEREST 1 0.0002
435 CARDIAC PACEMAKER INSERTION 1 0.0002
436 ACCIDENT 2 0.0002
437 WRIST FRACTURE 2 0.0002
438 TOOTHACHE 3 0.0002
439 MENTAL IMPAIRMENT 4 0.0002
440 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
441 SMALL INTESTINAL OBSTRUCTION 2 0.0002
442 CYST 2 0.0002
443 INFUSION SITE SWELLING 1 0.0002
444 FOOT FRACTURE 3 0.0002
445 HERPES ZOSTER 9 0.0002
446 UNRESPONSIVE TO STIMULI 4 0.0002
447 BREAST CANCER STAGE III 1 0.0002
448 DYSPHONIA 9 0.0002
449 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
450 DEAFNESS 4 0.0002
451 PRODUCT PREPARATION ISSUE 1 0.0002
452 SOMNAMBULISM 1 0.0002
453 BEDRIDDEN 2 0.0002
454 PRODUCT FORMULATION ISSUE 1 0.0002
455 ADVERSE REACTION 2 0.0002
456 TERMINAL STATE 1 0.0001
457 DYSKINESIA 6 0.0001
458 RASH PRURITIC 8 0.0001
459 PRODUCT LABEL ISSUE 1 0.0001
460 LIMB INJURY 4 0.0001
461 IMPAIRED GASTRIC EMPTYING 2 0.0001
462 ABNORMAL LOSS OF WEIGHT 1 0.0001
463 GINGIVAL BLEEDING 2 0.0001
464 BLOOD TESTOSTERONE DECREASED 1 0.0001
465 RESPIRATION ABNORMAL 1 0.0001
466 JOINT EFFUSION 1 0.0001
467 LYMPHOEDEMA 1 0.0001
468 HAIR GROWTH ABNORMAL 1 0.0001
469 FORMICATION 1 0.0001
470 COORDINATION ABNORMAL 2 0.0001
471 NECK PAIN 8 0.0001
472 RIGHT VENTRICULAR FAILURE 1 0.0001
473 HALLUCINATION, VISUAL 3 0.0001
474 PULMONARY TOXICITY 1 0.0001
475 RETCHING 3 0.0001
476 JOINT INJURY 3 0.0001
477 ARTHRITIS 11 0.0001
478 SUBDURAL HAEMATOMA 2 0.0001
479 TONGUE DISORDER 1 0.0001
480 PRODUCT DISPENSING ERROR 3 0.0001
481 FAECES SOFT 1 0.0001
482 INTENTIONAL UNDERDOSE 1 0.0001
483 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
484 INCORRECT DOSE ADMINISTERED 31 0.0001
485 ANGIOEDEMA 6 0.0001
486 TOOTH DISORDER 3 0.0001
487 NERVOUSNESS 7 0.0001
488 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
489 GENERAL SYMPTOM 1 0.0001
490 PAROSMIA 1 0.0001
491 TROPONIN INCREASED 1 0.0001
492 DRUG DISPENSING ERROR 2 0.0001
493 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
494 ATRIOVENTRICULAR BLOCK 1 0.0001
495 HYPERSENSITIVITY 24 0.0001
496 MUSCULOSKELETAL CHEST PAIN 2 0.0001
497 HAEMORRHAGIC STROKE 1 0.0001
498 GASTROINTESTINAL INFLAMMATION 1 0.0001
499 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
500 AFFECTIVE DISORDER 1 0.0001
501 FALL 42 0.0001
502 PRODUCT PRESCRIBING ERROR 3 0.0001
503 HALLUCINATION, AUDITORY 2 0.0001
504 SKIN BURNING SENSATION 9 0.0001
505 ATRIAL FLUTTER 1 0.0001
506 HIP FRACTURE 4 0.0001
507 SENSORY LOSS 1 0.0001
508 INSOMNIA 33 0.0001
509 EXTRA DOSE ADMINISTERED 5 0.0001
510 PRESYNCOPE 3 0.0001
511 PRODUCT USE ISSUE 23 0.0001
512 POLYURIA 1 0.0001
513 ABNORMAL FAECES 1 0.0001
514 HYPERAESTHESIA 1 0.0001
515 ESCHERICHIA INFECTION 1 0.0001
516 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 1 0.0001
517 VISUAL IMPAIRMENT 15 0.0001
518 SPINAL COMPRESSION FRACTURE 1 0.0001
519 MUSCLE INJURY 1 0.0001
520 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
521 SECOND PRIMARY MALIGNANCY 1 0.0001
522 ROAD TRAFFIC ACCIDENT 5 0.0001
523 DRUG USE DISORDER 1 0.0001
524 CANDIDA INFECTION 2 0.0001
525 THERAPY CESSATION 6 0.0001
526 SCAR 2 0.0001
527 SKIN HYPERPIGMENTATION 1 0.0001
528 DEVICE LEAKAGE 5 0.0001
529 URINE OUTPUT DECREASED 1 0.0001
530 GRIP STRENGTH DECREASED 1 0.0001
531 COLD SWEAT 2 0.0001
532 PRODUCT COMMUNICATION ISSUE 1 0.0001
533 THROAT TIGHTNESS 3 0.0001
534 OROPHARYNGEAL DISCOMFORT 1 0.0001
535 RESPIRATORY ARREST 3 0.0001
536 RASH 47 0.0001
537 WOUND 3 0.0001
538 PRODUCT DOSE OMISSION 7 0.0001
539 HEPATIC ENCEPHALOPATHY 1 0.0001
540 HYPOAESTHESIA 16 0.0001
541 NEOPLASM MALIGNANT 7 0.0001
542 SLEEP APNOEA SYNDROME 2 0.0001
543 MIGRAINE 10 0.0001
544 HYPERSOMNIA 3 0.0001
545 AFFECT LABILITY 1 0.0001
546 VITAMIN D DEFICIENCY 1 0.0001
547 PHARYNGEAL SWELLING 1 0.0001
548 BODY TEMPERATURE DECREASED 1 0.0001
549 DISORIENTATION 4 0.0001
550 BLADDER DISORDER 1 0.0001
551 OVARIAN CYST 1 0.0001
552 BURNING SENSATION 7 0.0001
553 APHASIA 3 0.0001
554 GAIT DISTURBANCE 19 0.0001
555 FEEDING DISORDER 2 0.0001
556 DRY MOUTH 8 0.0001
557 TOOTH ABSCESS 1 0.0001
558 DRUG ADMINISTRATION ERROR 3 0.0001
559 HELICOBACTER INFECTION 1 0.0001
560 LIMB DISCOMFORT 3 0.0001
561 WEIGHT DECREASED 27 0.0001
562 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
563 DYSPHAGIA 9 0.0001
564 RENAL PAIN 1 0.0001
565 BREAST PAIN 1 0.0001
566 IRRITABLE BOWEL SYNDROME 2 0.0001
567 LIVER FUNCTION TEST INCREASED 2 0.0001
568 BREAST CANCER METASTATIC 1 0.0001
569 PRURITUS GENERALISED 2 0.0001
570 BIPOLAR DISORDER 1 0.0001
571 SEPTIC SHOCK 4 0.0001
572 PRODUCT PRESCRIBING ISSUE 2 0.0001
573 PULMONARY THROMBOSIS 1 0.0001
574 OESOPHAGITIS 1 0.0001
575 WOUND INFECTION 1 0.0001
576 STAPHYLOCOCCAL INFECTION 3 0.0001
577 GASTROINTESTINAL DISORDER 8 0.0001
578 RASH PAPULAR 2 0.0001
579 INTESTINAL PERFORATION 1 0.0001
580 BLISTER 5 0.0001
581 OXYGEN SATURATION DECREASED 5 0.0001
582 IMPAIRED DRIVING ABILITY 1 0.0001
583 SCAB 1 0.0001
584 LETHARGY 5 0.0001
585 MUSCLE TWITCHING 2 0.0001
586 CONFUSIONAL STATE 14 0.0001
587 UNINTENTIONAL MEDICAL DEVICE REMOVAL 1 0.0001
588 DELIRIUM 3 0.0001
589 BACK PAIN 20 0.0001
590 HYPOXIA 3 0.0001
591 CHOLECYSTITIS 1 0.0001
592 MYOCLONUS 1 0.0001
593 MACULAR DEGENERATION 1 0.0001
594 BLOOD PRESSURE FLUCTUATION 2 0.0001
595 THYROID CANCER 1 0.0001
596 CEREBROVASCULAR ACCIDENT 14 0.0001
597 BURSITIS 1 0.0001
598 NO THERAPEUTIC RESPONSE 1 0.0001
599 MUSCLE SPASMS 15 0.0001
600 RESPIRATORY DEPRESSION 1 0.0001
601 ENCEPHALOPATHY 2 0.0001
602 TENDON RUPTURE 1 0.0001
603 ABASIA 2 0.0001
604 WEIGHT INCREASED 18 0.0001
605 MEMORY IMPAIRMENT 11 0.0001
606 PNEUMONIA ASPIRATION 2 0.0001
607 INJECTION SITE DISCOLOURATION 1 0.0001
608 SECRETION DISCHARGE 1 0.0001
609 DYSARTHRIA 3 0.0001
610 HALLUCINATION 6 0.0001
611 POISONING 1 0.0001
612 DRUG DOSE OMISSION 13 0.0001
613 FLUID RETENTION 4 0.0001
614 INTRAOCULAR PRESSURE INCREASED 1 0.0001
615 INFUSION SITE PAIN 1 0.0001
616 ABDOMINAL DISCOMFORT 13 0.0001
617 SKIN ULCER 2 0.0001
618 HIATUS HERNIA 1 0.0001
619 RASH GENERALISED 2 0.0001
620 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
621 SEDATION 2 0.0001
622 SPEECH DISORDER 4 0.0001
623 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
624 INCORRECT PRODUCT STORAGE 1 0.0001
625 ORAL CANDIDIASIS 1 0.0001
626 IMMUNE SYSTEM DISORDER 1 0.0001
627 TOOTH INFECTION 1 0.0001
628 DEVICE DIFFICULT TO USE 5 0.0001
629 BLOOD PRESSURE DECREASED 5 0.0001
630 JOINT RANGE OF MOTION DECREASED 1 0.0001
631 QUALITY OF LIFE DECREASED 1 0.0001
632 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
633 PAIN OF SKIN 2 0.0001
634 DISTURBANCE IN ATTENTION 4 0.0001
635 NEUROPATHY PERIPHERAL 7 0.0001
636 PNEUMONITIS 2 0.0001
637 AKATHISIA 1 0.0001
638 OSTEOPOROSIS 3 0.0001
639 CORONARY ARTERY OCCLUSION 1 0.0001
640 SKIN LESION 2 0.0001
641 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
642 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
643 ABNORMAL DREAMS 2 0.0001
644 FEELING COLD 2 0.0001
645 HAEMOPTYSIS 2 0.0001
646 APHONIA 1 0.0001
647 PAIN IN EXTREMITY 21 0.0001
648 BLOOD TEST ABNORMAL 1 0.0001
649 SKIN REACTION 1 0.0001
650 FEELING ABNORMAL 17 0.0001
651 BLINDNESS UNILATERAL 1 0.0001
652 TARDIVE DYSKINESIA 2 0.0001
653 SINUS TACHYCARDIA 1 0.0001
654 CARDIOGENIC SHOCK 1 0.0001
655 IMPAIRED QUALITY OF LIFE 1 0.0001
656 ACCIDENTAL UNDERDOSE 1 0.0001
657 PARAESTHESIA ORAL 1 0.0001
658 DEVICE DISLOCATION 3 0.0001
659 HYPOKINESIA 1 0.0001
660 CONSTIPATION 15 0.0001
661 RESPIRATORY FAILURE 5 0.0001
662 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
663 PALPITATIONS 8 0.0001
664 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
665 SKIN HAEMORRHAGE 1 0.0001
666 THERAPY NON-RESPONDER 3 0.0001
667 TREMOR 11 0.0001
668 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
669 DEVICE FAILURE 1 0.0001
670 BLOOD PRESSURE INCREASED 10 0.0001
671 SKIN DISCOLOURATION 3 0.0001
672 INJECTION SITE RASH 2 0.0001
673 HYPOKALAEMIA 3 0.0001
674 DEVICE RELATED INFECTION 1 0.0001
675 EMOTIONAL DISORDER 2 0.0001
676 LYMPHOMA 1 0.0001
677 DELUSION 1 0.0001
678 BLOOD CHOLESTEROL INCREASED 3 0.0001
679 COGNITIVE DISORDER 3 0.0001
680 BASAL CELL CARCINOMA 1 0.0001
681 SWOLLEN TONGUE 2 0.0001
682 ASTHENIA 24 0.0001
683 HEADACHE 40 0.0001
684 SICKLE CELL ANAEMIA WITH CRISIS 1 0.0001
685 ANXIETY 18 0.0001
686 RESPIRATORY TRACT CONGESTION 1 0.0001
687 ULCER 1 0.0001
688 CYSTITIS 2 0.0001
689 OBESITY 1 0.0001
690 SEPSIS 7 0.0001
691 ABSCESS 1 0.0001
692 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
693 SENSORY DISTURBANCE 1 0.0001
694 MUSCLE TIGHTNESS 1 0.0001
695 SWELLING FACE 4 0.0001
696 BLOOD CREATININE INCREASED 4 0.0001
697 DYSPEPSIA 6 0.0001
698 VENTRICULAR TACHYCARDIA 1 0.0001
699 PHOTOSENSITIVITY REACTION 1 0.0001
700 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
701 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
702 CYTOMEGALOVIRUS INFECTION 1 0.0001
703 LIP SWELLING 2 0.0001
704 URINARY RETENTION 2 0.0001
705 CELLULITIS 3 0.0001
706 ANGER 2 0.0001
707 HEMIPARESIS 1 0.0001
708 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
709 DIZZINESS 29 0.0001
710 PARANOIA 1 0.0001
711 BALANCE DISORDER 5 0.0001
712 FATIGUE 45 0.0001
713 ABDOMINAL DISTENSION 6 0.0001
714 ORTHOSTATIC HYPOTENSION 1 0.0001
715 PRURITUS 22 0.0001
716 RASH MACULAR 2 0.0001
717 MUSCULOSKELETAL STIFFNESS 5 0.0001
718 HYPERKALAEMIA 2 0.0001
719 HEART RATE DECREASED 2 0.0001
720 INJURY 4 0.0001
721 DEPRESSED MOOD 3 0.0001
722 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
723 LYMPHOCYTE COUNT DECREASED 1 0.0001
724 BRADYCARDIA 3 0.0001
725 LYMPHADENOPATHY 2 0.0001
726 DRUG ERUPTION 1 0.0001
727 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
728 GALLBLADDER DISORDER 1 0.0001
729 THIRST 1 0.0001
730 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
731 CONDITION AGGRAVATED 17 0.0001
732 ADVERSE DRUG REACTION 5 0.0001
733 GASTROENTERITIS VIRAL 1 0.0001
734 OSTEOMYELITIS 1 0.0001
735 PELVIC PAIN 1 0.0001
736 CRYING 2 0.0001
737 BONE DISORDER 1 0.0001
738 SOMNOLENCE 11 0.0001
739 SUICIDAL IDEATION 5 0.0001
740 AGITATION 4 0.0001
741 HAEMATOCHEZIA 3 0.0001
742 DYSURIA 2 0.0001
743 ANAPHYLACTIC REACTION 3 0.0001
744 BRONCHITIS 4 0.0001
745 URTICARIA 9 0.0001
746 THINKING ABNORMAL 1 0.0001
747 NAUSEA 42 0.0001
748 UNEVALUABLE EVENT 4 0.0001
749 URINARY TRACT INFECTION 9 0.0001
750 COLITIS 2 0.0001
751 MUSCULOSKELETAL DISORDER 1 0.0001
752 POST PROCEDURAL COMPLICATION 1 0.0001
753 SEROTONIN SYNDROME 1 0.0001
754 DRUG PRESCRIBING ERROR 1 0.0001
755 LOWER LIMB FRACTURE 1 0.0001
756 CONTUSION 5 0.0001
757 HYPERTENSION 11 0.0001
758 PERIPHERAL SWELLING 8 0.0001
759 GLAUCOMA 1 0.0001
760 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
761 HERNIA 1 0.0001
762 DECREASED APPETITE 12 0.0001
763 ABDOMINAL PAIN 12 0.0001
764 DYSTONIA 1 0.0001
765 HAEMORRHOIDS 1 0.0001
766 PLASMA CELL MYELOMA 2 0.0001
767 DYSPNOEA 29 0.0001
768 ORAL HERPES 1 0.0001
769 VISION BLURRED 7 0.0001
770 KIDNEY INFECTION 1 0.0001
771 PARAESTHESIA 8 0.0001
772 WHEEZING 3 0.0001
773 SINUS DISORDER 1 0.0001
774 CATARACT 3 0.0001
775 BLOOD PRESSURE ABNORMAL 1 0.0001
776 PRESCRIBED UNDERDOSE 1 0.0001
777 PREGNANCY 1 0.0000
778 JOINT SWELLING 6 0.0000
779 THERAPEUTIC RESPONSE DECREASED 3 0.0000
780 PRODUCT ADMINISTRATION ERROR 1 0.0000
781 OEDEMA PERIPHERAL 6 0.0000
782 BONE MARROW FAILURE 1 0.0000
783 FLUSHING 5 0.0000
784 BLINDNESS 2 0.0000
785 NASOPHARYNGITIS 9 0.0000
786 INFLUENZA LIKE ILLNESS 4 0.0000
787 CHEST PAIN 9 0.0000
788 ABDOMINAL PAIN UPPER 10 0.0000
789 TOOTH LOSS 1 0.0000
790 DIARRHOEA 31 0.0000
791 PULMONARY HYPERTENSION 1 0.0000
792 MOUTH ULCERATION 1 0.0000
793 OSTEOARTHRITIS 2 0.0000
794 RENAL FAILURE ACUTE 2 0.0000
795 EATING DISORDER 1 0.0000
796 VOMITING 22 0.0000
797 IMPAIRED WORK ABILITY 1 0.0000
798 PNEUMONIA 15 0.0000
799 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
800 FEBRILE NEUTROPENIA 3 0.0000
801 DEHYDRATION 6 0.0000
802 TRANSAMINASES INCREASED 1 0.0000
803 COLITIS ULCERATIVE 2 0.0000
804 CHROMATURIA 1 0.0000
805 HEART RATE IRREGULAR 1 0.0000
806 ASTHMA 5 0.0000
807 DEPRESSION 10 0.0000
808 SHOCK 1 0.0000
809 ADVERSE EVENT 4 0.0000
810 PERICARDIAL EFFUSION 1 0.0000
811 COUGH 12 0.0000
812 SWELLING 4 0.0000
813 THERAPY INTERRUPTED 3 0.0000
814 RASH ERYTHEMATOUS 2 0.0000
815 HEPATIC CANCER 1 0.0000
816 LOCALISED INFECTION 1 0.0000
817 MYALGIA 7 0.0000
818 ATRIAL FIBRILLATION 4 0.0000
819 CEREBRAL INFARCTION 1 0.0000
820 LIVER INJURY 1 0.0000
821 EPISTAXIS 3 0.0000
822 HOT FLUSH 3 0.0000
823 ABDOMINAL PAIN LOWER 1 0.0000
824 CHRONIC KIDNEY DISEASE 3 0.0000
825 PRODUCT COMPLAINT 1 0.0000
826 HAEMATEMESIS 1 0.0000
827 HYPOPHAGIA 1 0.0000
828 HOSPITALISATION 6 0.0000
829 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
830 ANAPHYLACTIC SHOCK 1 0.0000
831 DIPLOPIA 1 0.0000
832 ARTHRALGIA 16 0.0000
833 RESPIRATORY TRACT INFECTION 1 0.0000
834 MUCOSAL INFLAMMATION 1 0.0000
835 EAR INFECTION 1 0.0000
836 CARDIAC FAILURE 3 0.0000
837 THROMBOSIS 3 0.0000
838 FEAR 1 0.0000
839 MOOD ALTERED 1 0.0000
840 MALAISE 16 0.0000
841 DIVERTICULITIS 1 0.0000
842 DEMENTIA 1 0.0000
843 ALOPECIA 7 0.0000
844 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
845 PAIN IN JAW 1 0.0000
846 MUSCULAR WEAKNESS 4 0.0000
847 RED BLOOD CELL COUNT DECREASED 1 0.0000
848 EYE IRRITATION 2 0.0000
849 SEIZURE 4 0.0000
850 BONE PAIN 2 0.0000
851 CHILLS 4 0.0000
852 NASAL CONGESTION 2 0.0000
853 ASCITES 1 0.0000
854 LABORATORY TEST ABNORMAL 1 0.0000
855 TACHYCARDIA 3 0.0000
856 URINARY INCONTINENCE 1 0.0000
857 RESPIRATORY DISORDER 1 0.0000
858 IRRITABILITY 2 0.0000
859 HEPATIC FAILURE 1 0.0000
860 PLEURAL EFFUSION 2 0.0000
861 VERTIGO 2 0.0000
862 EPILEPSY 1 0.0000
863 FEELING HOT 2 0.0000
864 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
865 OROPHARYNGEAL PAIN 3 0.0000
866 FEMUR FRACTURE 1 0.0000
867 BONE DENSITY DECREASED 1 0.0000
868 HEAD INJURY 1 0.0000
869 MOOD SWINGS 1 0.0000
870 HYPOTHYROIDISM 1 0.0000
871 LOSS OF CONSCIOUSNESS 4 0.0000
872 DEEP VEIN THROMBOSIS 2 0.0000
873 AMNESIA 2 0.0000
874 CHOLELITHIASIS 1 0.0000
875 IMPAIRED HEALING 1 0.0000
876 DEATH 26 0.0000
877 INFUSION RELATED REACTION 2 0.0000
878 FUNGAL INFECTION 1 0.0000
879 INJECTION SITE PRURITUS 2 0.0000
880 EYE PRURITUS 1 0.0000
881 TOXICITY TO VARIOUS AGENTS 5 0.0000
882 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
883 CHEST DISCOMFORT 3 0.0000
884 HAEMOGLOBIN DECREASED 3 0.0000
885 HAEMATURIA 1 0.0000
886 ERYTHEMA 6 0.0000
887 GASTRIC DISORDER 1 0.0000
888 INJECTION SITE REACTION 2 0.0000
889 NIGHTMARE 1 0.0000
890 DEVICE USE ERROR 1 0.0000
891 NEOPLASM PROGRESSION 1 0.0000
892 HAEMORRHAGE 3 0.0000
893 MYOCARDIAL INFARCTION 5 0.0000
894 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
895 INFECTION 4 0.0000
896 PANIC ATTACK 1 0.0000
897 UNDERDOSE 2 0.0000
898 ACCIDENTAL OVERDOSE 1 0.0000
899 THROMBOCYTOPENIA 3 0.0000
900 DYSPNOEA EXERTIONAL 1 0.0000
901 INTESTINAL OBSTRUCTION 1 0.0000
902 DIABETES MELLITUS 2 0.0000
903 ACUTE KIDNEY INJURY 4 0.0000
904 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
905 DRUG INTERACTION 4 0.0000
906 EMOTIONAL DISTRESS 3 0.0000
907 PSORIATIC ARTHROPATHY 1 0.0000
908 DEVICE BREAKAGE 1 0.0000
909 NEUTROPHIL COUNT DECREASED 1 0.0000
910 LUNG NEOPLASM MALIGNANT 1 0.0000
911 CARDIAC ARREST 2 0.0000
912 TREATMENT FAILURE 2 0.0000
913 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
914 WITHDRAWAL SYNDROME 1 0.0000
915 RENAL IMPAIRMENT 2 0.0000
916 SKIN EXFOLIATION 2 0.0000
917 PYREXIA 8 0.0000
918 MENTAL DISORDER 1 0.0000
919 DRUG WITHDRAWAL SYNDROME 2 0.0000
920 DRY SKIN 3 0.0000
921 PULMONARY OEDEMA 1 0.0000
922 DEVICE ISSUE 2 0.0000
923 NEPHROLITHIASIS 1 0.0000
924 TINNITUS 1 0.0000
925 RENAL DISORDER 1 0.0000
926 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
927 CARDIAC DISORDER 2 0.0000
928 BLOOD GLUCOSE INCREASED 4 0.0000
929 OCULAR HYPERAEMIA 1 0.0000
930 ANAEMIA 4 0.0000
931 MULTIPLE SCLEROSIS 1 0.0000
932 BLOOD GLUCOSE DECREASED 1 0.0000
933 DRUG INTOLERANCE 2 0.0000
934 LUNG DISORDER 1 0.0000
935 HEART RATE INCREASED 2 0.0000
936 SYNCOPE 2 0.0000
937 ILLNESS 2 0.0000
938 INFLAMMATION 1 0.0000
939 PANCREATITIS 1 0.0000
940 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
941 PLATELET COUNT DECREASED 2 0.0000
942 OVERDOSE 4 0.0000
943 OEDEMA 1 0.0000
944 TREATMENT NONCOMPLIANCE 1 0.0000
945 PANCYTOPENIA 1 0.0000
946 RHEUMATOID ARTHRITIS 2 0.0000
947 CONVULSION 1 0.0000
948 COVID-19 3 0.0000
949 DISEASE PROGRESSION 2 0.0000
950 STOMATITIS 1 0.0000
951 INJECTION SITE ERYTHEMA 2 0.0000
952 EXPOSURE DURING PREGNANCY 1 0.0000
953 INTENTIONAL OVERDOSE 1 0.0000
954 HYPOTENSION 3 0.0000
955 NEUTROPENIA 2 0.0000
956 HEPATIC ENZYME INCREASED 1 0.0000
957 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
958 SLEEP DISORDER 1 0.0000
959 DYSGEUSIA 1 0.0000
960 INJECTION SITE BRUISING 1 0.0000
961 CARDIAC FAILURE CONGESTIVE 1 0.0000
962 PROSTATE CANCER 1 0.0000
963 BREAST CANCER 1 0.0000
964 PULMONARY EMBOLISM 1 0.0000
965 INJECTION SITE PAIN 3 0.0000
966 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
967 SINUSITIS 1 0.0000
968 INFLUENZA 1 0.0000
969 PSORIASIS 1 0.0000